← All trials
NCT04483830
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 5, 2020
- Primary completion
- Aug 6, 2020
- Completion date
- Sep 7, 2020
- First posted
- Jul 23, 2020
- Last posted
- Sep 9, 2020
- Enrollment
- 243
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Alfasigma S.p.A.Lead sponsor
- Alfasigma S.p.A.Collaborator
- Alfasigma S.p.A.Reponsible party - principal investigator
- Alfasigma S.p.A.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.